I’m not sure what to do. I see they’re making some progress in Europe with new vaccine approvals, and there’s talk of advances in their pipeline, which sounds promising. But the stock is still way down from its highs, and earnings aren’t looking great. I’m not a financial expert, just someone who believed in the company’s potential. Now I’m wondering - should I hang on and hope for a real turnaround, or cut my losses before things get worse?
There are no replies in this thread yet. Be the first to post a reply below: